NPC(600713)2025-04-29 12:20Financial Performance - The company's operating revenue for the first quarter was RMB 14,246,884,352.70, an increase of 2.11% compared to RMB 13,952,545,044.79 in the same period last year[4] - Net profit attributable to shareholders was RMB 177,360,973.00, reflecting an increase of 11.49% from RMB 159,082,706.83 year-on-year[4] - The basic earnings per share rose to RMB 0.135, up 9.76% from RMB 0.123 in the previous year[4] - Total operating revenue for Q1 2025 reached CNY 14.25 billion, a 2.1% increase from CNY 13.95 billion in Q1 2024[48] - Net profit for Q1 2025 was CNY 215.58 million, up 9.4% from CNY 196.95 million in Q1 2024[48] - Operating profit for Q1 2025 was CNY 274.94 million, compared to CNY 263.54 million in Q1 2024, reflecting a growth of 4.9%[48] - The company's total equity rose to CNY 8.01 billion in Q1 2025, compared to CNY 7.79 billion in Q1 2024, indicating a growth of 2.8%[46] - Basic earnings per share for Q1 2025 were CNY 0.135, up from CNY 0.123 in Q1 2024, representing a 9.8% increase[49] Assets and Liabilities - Total assets at the end of the reporting period reached RMB 33,479,449,255.38, a 9.15% increase from RMB 30,673,626,932.52 at the end of the previous year[4] - The company's total assets reached CNY 33.48 billion in Q1 2025, up from CNY 30.67 billion in Q1 2024, indicating an increase of 9.2%[46] - Total liabilities increased to CNY 25.47 billion in Q1 2025, up from CNY 22.89 billion in Q1 2024, marking an increase of 11.3%[46] - The company's total liabilities increased to CNY 13.13 billion as of March 31, 2025, from CNY 12.44 billion at the end of 2024, reflecting a rise of approximately 5.5%[55] Cash Flow - The net cash flow from operating activities was negative at RMB -3,600,439,125.40, an improvement from RMB -3,893,131,191.42 in the same period last year[4] - Cash flow from operating activities showed a net outflow of CNY 3.60 billion in Q1 2025, an improvement from a net outflow of CNY 3.89 billion in Q1 2024[51] - The company's cash flow from operating activities showed a net outflow of CNY 1.46 billion in Q1 2025, compared to a net outflow of CNY 828.41 million in Q1 2024, indicating a worsening cash flow situation[60] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,410[7] - The largest shareholder, Nanjing New Industry Investment Group Co., Ltd., holds 578,207,286 shares, representing 44.16% of the total shares[7] Fundraising and Investments - The company issued 10,814,910 convertible bonds with a total fundraising amount of RMB 1,081,491,000.00, net proceeds amounting to RMB 1,069,040,922.31 after deducting issuance costs[9] - The company has authorized the use of up to RMB 700 million of temporarily idle raised funds for cash management, with RMB 667 million already utilized in various financial products[15] - The company has a balance of USD 200 million in cross-border financing business as of the end of the reporting period[33] Incentive Plans and Stock Activities - The company completed the second unlock period of its 2021 restricted stock incentive plan, allowing 373 individuals to unlock a total of 4,849,614 shares[18] - The 2025 restricted stock incentive plan was approved, allowing for the grant of up to 18 million shares to eligible participants, with no objections raised during the public notice period[19] - The company approved a stock repurchase plan with a total funding of no less than RMB 70 million and no more than RMB 131.58 million, with a repurchase price not exceeding RMB 7.31 per share[24] - As of April 24, 2025, the company has repurchased a total of 14.5853 million shares, accounting for 1.11% of the total share capital, with a total payment of RMB 71.598 million[26] Operational Developments - The company has initiated construction on several projects, including the Fujian Tongchun Biopharmaceutical Industrial Park and the Nanjing Medicine Central Logistics Center Phase II[37][38] - The company has appointed Lixin Certified Public Accountants as its financial and internal control audit firm for the fiscal year 2025, with an audit fee not exceeding RMB 3.2 million[40] Other Financial Metrics - The company's inventory as of March 31, 2025, was RMB 6.277 billion, showing a slight decrease from RMB 6.286 billion at the end of 2024[45] - The company’s long-term equity investments were valued at RMB 70.054 million as of March 31, 2025, a slight decrease from RMB 70.566 million at the end of 2024[45] - Research and development expenses decreased to CNY 1.05 million in Q1 2025 from CNY 2.03 million in Q1 2024, a reduction of about 48.6%[57] - The company reported a significant increase in other receivables, which rose to CNY 10.02 billion as of March 31, 2025, compared to CNY 7.88 billion at the end of 2024, an increase of about 27.1%[54] - The company’s financial expenses increased to CNY 16.06 million in Q1 2025 from CNY 9.60 million in Q1 2024, an increase of approximately 67.1%[57]